Skip to content

Ali Alsalahat

NPI 1437837168ActiveIndividual· Psychiatry & Neurology, Neurology· Omaha, NE

Psychiatry & Neurology, Neurology in Omaha, Nebraska, licensed in NE, with an NPI issued in July 2023. Enrolled in Medicare as order and referring only - neurology. Genzyme Corporation reported $34.88 in payments in 2025, mostly food and beverage.

Overview

NPI1437837168
StatusActive
Entity typeIndividual
Sole proprietorNo
NPI issuedJul 11, 2023
Last updated in NPPESJul 11, 2023
Certified by providerJul 11, 2023

Specialties and licenses

TaxonomyCodeLicenseState
Psychiatry & Neurology, Neurology Primary2084N0400X9804NE

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 4, 2026No match—
New York OMIG · Nov 4, 2026No match—
Ohio Medicaid · Nov 4, 2026No match—
Pennsylvania Medicheck · Nov 4, 2026No match—
Washington HCA · Nov 4, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Neurology (NE)

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$34.88 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Genzyme Corporation$34.881

What the 2025 payments were for

  • Food and Beverage$34.88 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Psychiatry & Neurology, Neurology providers in Omaha

All Psychiatry & Neurology, Neurology providers in Nebraska →